Newsletter Subject

FDA Panel Gives Thumbs Up to Earlier Use of CAR T-Cell Therapy in Multiple Myeloma

From

medpagetoday.com

Email Address

daily.headlines@broadcaster3.medpagetoday.com

Sent On

Tue, Mar 19, 2024 08:08 PM

Email Preheader Text

Oncology Update Tuesday, March 19, 2024 ADVERTISEMENT Exclusives & Features PURPOSE: The current app

[MEDPAGE TODAY]( Oncology Update Tuesday, March 19, 2024 [FDA Panel Gives Thumbs Up to Earlier Use of CAR T-Cell Therapy in Multiple Myeloma]( [FDA Approves First CAR-T for Chronic Lymphocytic Leukemia]( [How Often Should Immunocompromised People Get a COVID Booster?]( [EPA Imposes New Limit on Medical Sterilization Chemical, Citing Cancer Risk]( [Gynecologic Oncology May Face a Future of Too Few Cases, Too Many Docs]( ADVERTISEMENT Exclusives & Features [Match Rates Stable as Applicants, Positions Reach All-Time Highs]( [Noninvasive Stratification of Colon Cancer by Multiplex PET Imaging.]( PURPOSE: The current approach for molecular subtyping of colon cancer relies on gene expression profiling, which is invasive and has limited ability to reveal dynamics and spatial heterogeneity.... [READ MORE]( [Patients hate American health care. But presidential candidates aren't talking about it.]( Although health care has not come up much as a campaign issue for the presumptive candidates, people still consider it a major public problem. [READ MORE]( [Inside the cancer waiting room where hope hangs in the balance]( Frozen in fear inside the cancer waiting room, where hope hangs in the balance. [READ MORE]( [Raludotatug Deruxtecan Promising in Platinum-Resistant Advanced Ovarian Cancer]( SAN DIEGO -- Treatment with raludotatug deruxtecan (R-DXd) led to an "exciting" response rate among patients with heavily pretreated, platinum-resistant advanced ovarian cancer, according to an... [READ MORE]( [Nearly 20,000 Missed Prostate Cancer Diagnoses Due To Covid-19 Pandemic]( The Covid-19 pandemic has led to delays in diagnosing prostate cancer that in turn can significantly affect odds of survival and treatment options. [READ MORE]( [A Property of Everyday Health group]( © 2024 MedPage Today, LLC. MedPage Today is among the federally registered trademarks of MedPage Today, LLC, and may not be used by third parties without explicit permission. You have received this email because you have registered to receive emails at www.medpagetoday.com, with the email address: {EMAIL} [Manage Email Preferences]( | [Unsubscribe](lst=NL_Spec_Oncology_Update?xid=nl_mpt_Oncology_update_2024-03-19&eun=g1020308d0r) | [Terms of Use]( | [Privacy Policy]( Technical Questions: feedback@medpagetoday.com 114 5th Avenue, 15th Floor New York, NY 10011

Marketing emails from medpagetoday.com

View More
Sent On

08/12/2024

Sent On

08/11/2024

Sent On

07/11/2024

Sent On

07/11/2024

Sent On

06/11/2024

Sent On

04/11/2024

Email Content Statistics

Subscribe Now

Subject Line Length

Data shows that subject lines with 6 to 10 words generated 21 percent higher open rate.

Subscribe Now

Average in this category

Subscribe Now

Number of Words

The more words in the content, the more time the user will need to spend reading. Get straight to the point with catchy short phrases and interesting photos and graphics.

Subscribe Now

Average in this category

Subscribe Now

Number of Images

More images or large images might cause the email to load slower. Aim for a balance of words and images.

Subscribe Now

Average in this category

Subscribe Now

Time to Read

Longer reading time requires more attention and patience from users. Aim for short phrases and catchy keywords.

Subscribe Now

Average in this category

Subscribe Now

Predicted open rate

Subscribe Now

Spam Score

Spam score is determined by a large number of checks performed on the content of the email. For the best delivery results, it is advised to lower your spam score as much as possible.

Subscribe Now

Flesch reading score

Flesch reading score measures how complex a text is. The lower the score, the more difficult the text is to read. The Flesch readability score uses the average length of your sentences (measured by the number of words) and the average number of syllables per word in an equation to calculate the reading ease. Text with a very high Flesch reading ease score (about 100) is straightforward and easy to read, with short sentences and no words of more than two syllables. Usually, a reading ease score of 60-70 is considered acceptable/normal for web copy.

Subscribe Now

Technologies

What powers this email? Every email we receive is parsed to determine the sending ESP and any additional email technologies used.

Subscribe Now

Email Size (not include images)

Font Used

No. Font Name
Subscribe Now

Copyright © 2019–2025 SimilarMail.